Schedule 13D ownership disclosure

AUTOLUS THERAPEUTICS LTD

American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share · CUSIP: 05280R100

Event date: 2026-11-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BXLS V - Autobahn L.P.

    Shares: 20,485,611 · Class: 7.6%

  • Blackstone Life Sciences Associates V (CYM) L.L.C.

    Shares: 20,485,611 · Class: 7.6%

  • BXLS V L.L.C.

    Shares: 20,485,611 · Class: 7.6%

  • Blackstone Holdings II L.P.

    Shares: 20,485,611 · Class: 7.6%

  • Blackstone Holdings I/II GP L.L.C.

    Shares: 20,485,611 · Class: 7.6%

  • Blackstone Inc.Reported CIK 0001393818

    Shares: 20,485,611 · Class: 7.6%

  • Blackstone Group Management L.L.C.

    Shares: 20,485,611 · Class: 7.6%

  • Stephen A. Schwarzman

    Shares: 20,485,611 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-455574
Form type
SCHEDULE 13D/A
Filer
Autolus Therapeutics plc
CIK
CIK 1730463
Filed
Nov 10, 2026
Reporting period
Nov 06, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub